MedTrace Logo

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis

NCT02865447 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2022-08-02

No results posted yet for this study

Summary

Sponsor is conducting this post-market study to evaluate the clinical outcome and femoral bone mineral density (BMD) changes associated with the PROFEMUR® PRESERVE hip stem when used as indicated for primary total hip arthroplasty in patients with osteoarthritis of the hip joint.

Conditions

  • Joint Disease

Interventions

DEVICE

total hip arthroplasty implant

PROFEMUR PRESERVE total hip arthroplasty femoral stem

Sponsors & Collaborators

  • Orthopaedic Specialty Clinic of Spokane, PLLC

    collaborator OTHER

  • MicroPort Orthopedics Inc.

    lead INDUSTRY

Principal Investigators

  • David Scott, MD · Spokane Joint Replacement Center, Inc.

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-03-09
Primary Completion
2020-08-24
Completion
2020-08-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02865447 on ClinicalTrials.gov